Safety and tolerability of ALO-02 (oxycodone hydrochloride and sequestered naltrexone hydrochloride) extended-release capsules in older patients: a pooled analysis of two clinical trials

Curr Med Res Opinl
17 September 2019
https://pubmed.ncbi.nlm.nih.gov/31456431/

Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy

Int Immunopharmacol
09 August 2019
https://pubmed.ncbi.nlm.nih.gov/31404891/

Low-dose naltrexone safe, effective for neuropathic corneal pain

Healio News
25 October 2019
https://www.healio.com/news/ophthalmology/20191025/lowdose-naltrexone-safe-effective-for-neuropathic-corneal-pain

A Retrospective Review of Patients Prescribed Low Dose Naltrexone for Chronic Pain at a Single Institution

The Anesthesiology Annual Meeting
20 October 2019
http://www.asaabstracts.com/strands/asaabstracts/abstract.htm?year=2019&index=3&absnum=1499

Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain

Ocul Surf
12 Jan 2021
https://pubmed.ncbi.nlm.nih.gov/33450415/

Kris takes LDN for Chronic Lyme pain (Low-dose Naltrexone) from LDN Research Trust on Vimeo.

Low-dose Naltrexone (LDN) & Chronic Pain (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

Dr. Adrienne Junek, MD, CCFP, ABOIM

Low-dose Naltrexone (LDN) & Chronic Pain

A potential anti-inflammatory effect of low-dose naltrexone in fibromyalgia

J Pain
01 April 2015
https://www.jpain.org/article/S1526-5900(15)00362-4/abstract

The Holy Grail of Pharmaceuticals? - Dr Grana (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.